Keyphrases
MicroRNA Profile
100%
Bladder Cancer
100%
Neoadjuvant Chemotherapy
100%
Muscle-invasive
100%
MicroRNA
75%
Chemoresistance
50%
Therapeutic Response
50%
Radical Cystectomy
50%
Bladder Cancer Diagnosis
50%
Clinical Outcomes
25%
High Risk
25%
Treatment Protocol
25%
Cancer Patients
25%
Disease Stage
25%
Disease Progression
25%
Tumorigenesis
25%
Resistance to Chemotherapy
25%
Disease Prognosis
25%
Disease Risk
25%
Clinical Prognosis
25%
Poor Response
25%
MicroRNA-34a (miR-34a)
25%
MicroRNA Regulation
25%
MiRNA Expression Profile
25%
Profile Changes
25%
MiR-9
25%
Malignant Potential
25%
Tumor Diagnosis
25%
Diseases Therapeutic
25%
Non-muscle Invasive Bladder Cancer (NMIBC)
25%
Muscle-invasive Bladder Cancer
25%
Neoadjuvant Chemotherapy Response
25%
MiR-100
25%
MiR-146b
25%
MiR-193a-3p
25%
Pharmacology, Toxicology and Pharmaceutical Science
microRNA
100%
Biological Marker
100%
Bladder Cancer
100%
Chemotherapy
85%
Drug Resistance
28%
Disease
14%
Malignant Neoplasm
14%
Neoplasm
14%
Carcinogenesis
14%
Disease Exacerbation
14%
Non Muscle Invasive Bladder Cancer
14%
Muscle Invasive Bladder Cancer
14%
microRNA 100
14%
microRNA 9
14%
Biochemistry, Genetics and Molecular Biology
Decision Making
100%
MicroRNA
100%
Drug Resistance
66%
Carcinogenesis
33%